Humedix Co Ltd banner
H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 36 300 KRW 0.28% Market Closed
Market Cap: ₩407.6B

Relative Value

The Relative Value of one Humedix Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 36 300 KRW, Humedix Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Humedix Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Humedix Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Humedix Co Ltd
KOSDAQ:200670
376.1B KRW 2.3 6.8 4.5 5.6
US
Eli Lilly and Co
NYSE:LLY
879B USD 13.5 42.6 28.7 30.7
US
Johnson & Johnson
NYSE:JNJ
573.4B USD 6.1 21.4 14.9 18.3
CH
Roche Holding AG
SIX:ROG
257.8B CHF 4.2 20 11.8 13.3
UK
AstraZeneca PLC
LSE:AZN
224B GBP 5.1 29.1 16.2 22.8
CH
Novartis AG
SIX:NOVN
231.4B CHF 5.3 21.2 13.1 16.9
US
Merck & Co Inc
NYSE:MRK
286.7B USD 4.4 15.7 9.7 11.9
IE
Endo International PLC
LSE:0Y5F
240.1B USD 103.6 -82.1 380.1 953.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.5 10.6 7.8 9.2
US
Pfizer Inc
NYSE:PFE
156.1B USD 2.5 20.1 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD 2.5 17.1 7.2 8.8
P/E Multiple
Earnings Growth PEG
KR
H
Humedix Co Ltd
KOSDAQ:200670
Average P/E: 20.5
6.8
10%
0.7
US
Eli Lilly and Co
NYSE:LLY
42.6
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.4
7%
3.1
CH
Roche Holding AG
SIX:ROG
20
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.1
26%
1.1
CH
Novartis AG
SIX:NOVN
21.2
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.7
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -82.1 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
US
Pfizer Inc
NYSE:PFE
20.1
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
H
Humedix Co Ltd
KOSDAQ:200670
Average EV/EBITDA: 45.6
4.5
9%
0.5
US
Eli Lilly and Co
NYSE:LLY
28.7
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
UK
AstraZeneca PLC
LSE:AZN
16.2
13%
1.2
CH
Novartis AG
SIX:NOVN
13.1
5%
2.6
US
Merck & Co Inc
NYSE:MRK
9.7
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
380.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.8
1%
7.8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
H
Humedix Co Ltd
KOSDAQ:200670
Average EV/EBIT: 100.1
5.6
10%
0.6
US
Eli Lilly and Co
NYSE:LLY
30.7
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.3
7%
2.6
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
22.8
21%
1.1
CH
Novartis AG
SIX:NOVN
16.9
9%
1.9
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
953.2
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
3%
3.1
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett